ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Ghent University Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Ghent University Hospital takes part in 5 sessions at ESMO 2026 in Madrid. Its sessions focus on genitourinary cancers, biomarkers and reducing delays in diagnosis. They examine whether RNA can predict response and immune-related side effects in bladder cancer treated with pembrolizumab.
| Organization | ESMO 2026 Attendance |
|---|---|
Ghent University Hospital Gent, Belgium | |
Public university hospital in Ghent, Belgium, affiliated with Ghent University. | Poster Fri Oct 23 15:15–16:00 Association between prior treatment exposure and genomic alterations in metastatic castration-resistant prostate cancer: An ancillary study of the ProBio trial Genitourinary cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Chair Sat Oct 24 14:00–15:00 Talk Sat Oct 24 14:40–14:50 Chair Sun Oct 25 10:15–11:45 Emerging new systemic therapies for RCC Genitourinary cancers Chair Sun Oct 25 14:45–16:15 Rapid oral 2: Genitourinary tumours, renal and urothelial Genitourinary cancers Abstract Sun Oct 25 15:27–15:39 Invited Discussant 3591RO, 3612RO and 3615RO Genitourinary cancers Talk Sun Oct 25 16:05–16:20 Bite-size modules and certification: Part 1 Nursing & supportive care |
Find decision makers at Ghent University Hospital
Tell us what you sell and we’ll find the people at Ghent University Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction